HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA) Fundamental Analysis & Valuation

TSX-V:HAPB • CA41136M1023

Current stock price

0.05 CAD
0 (0%)
Last:

This HAPB.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HAPB.CA Profitability Analysis

1.1 Basic Checks

  • HAPB had negative earnings in the past year.
  • HAPB had a negative operating cash flow in the past year.
  • HAPB had negative earnings in each of the past 5 years.
  • In the past 5 years HAPB always reported negative operating cash flow.
HAPB.CA Yearly Net Income VS EBIT VS OCF VS FCFHAPB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -56.15%
ROE N/A
ROIC N/A
ROA(3y)-181.65%
ROA(5y)-163.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HAPB.CA Yearly ROA, ROE, ROICHAPB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

  • HAPB's Gross Margin has improved in the last couple of years.
  • HAPB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.68%
GM growth 5YN/A
HAPB.CA Yearly Profit, Operating, Gross MarginsHAPB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. HAPB.CA Health Analysis

2.1 Basic Checks

  • HAPB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HAPB has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, HAPB has a worse debt to assets ratio.
HAPB.CA Yearly Shares OutstandingHAPB.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
HAPB.CA Yearly Total Debt VS Total AssetsHAPB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • HAPB has an Altman-Z score of -10.82. This is a bad value and indicates that HAPB is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.82
ROIC/WACCN/A
WACC8.4%
HAPB.CA Yearly LT Debt VS Equity VS FCFHAPB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

  • A Current Ratio of 0.62 indicates that HAPB may have some problems paying its short term obligations.
  • A Quick Ratio of 0.51 indicates that HAPB may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.51
HAPB.CA Yearly Current Assets VS Current LiabilitesHAPB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. HAPB.CA Growth Analysis

3.1 Past

  • HAPB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.05%, which is quite impressive.
  • The Revenue has grown by 92.55% in the past year. This is a very strong growth!
  • Measured over the past years, HAPB shows a very negative growth in Revenue. The Revenue has been decreasing by -37.37% on average per year.
EPS 1Y (TTM)73.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%177.78%
Revenue 1Y (TTM)92.55%
Revenue growth 3Y-37.37%
Revenue growth 5YN/A
Sales Q2Q%195.57%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HAPB.CA Yearly Revenue VS EstimatesHAPB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. HAPB.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HAPB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HAPB.CA Price Earnings VS Forward Price EarningsHAPB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HAPB.CA Per share dataHAPB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HAPB.CA Dividend Analysis

5.1 Amount

  • No dividends for HAPB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HAPB.CA Fundamentals: All Metrics, Ratios and Statistics

HAPBEE TECHNOLOGIES-SUB VTG

TSX-V:HAPB (3/26/2026, 7:00:00 PM)

0.05

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-01
Earnings (Next)06-22
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners31.76%
Ins Owner ChangeN/A
Market Cap11.72M
Revenue(TTM)1.31M
Net Income(TTM)-1.70M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -56.15%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.89%
FCFM N/A
ROA(3y)-181.65%
ROA(5y)-163.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.68%
GM growth 5YN/A
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.51
Altman-Z -10.82
F-Score4
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%177.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)92.55%
Revenue growth 3Y-37.37%
Revenue growth 5YN/A
Sales Q2Q%195.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y55.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.27%
OCF growth 3YN/A
OCF growth 5YN/A

HAPBEE TECHNOLOGIES-SUB VTG / HAPB.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to HAPB.CA.


Can you provide the valuation status for HAPBEE TECHNOLOGIES-SUB VTG?

ChartMill assigns a valuation rating of 0 / 10 to HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA). This can be considered as Overvalued.


Can you provide the profitability details for HAPBEE TECHNOLOGIES-SUB VTG?

HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA) has a profitability rating of 1 / 10.